Viral coinfections in children with invasive pneumococcal disease

Pediatric Infectious Disease Journal

Volumn 29, Issue 6, 2010, Pages 519-523

  Techasaensiri, Benyachalee ^a   Techasaensiri, Chonnamet ^a   Mejías, Asuncion ^a   McCracken, George H ^a   Ramilo, Octavio ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Invasive pneumococcal disease; Pneumococcal; Streptococcus pneumoniae; Viral and pneumococcal coinfection; Viral infection

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; CEFDINIR; CEFTRIAXONE;

ADENOVIRUS INFECTION; ADOLESCENT; ADULT; ARTICLE; BACTEREMIA; CHILD; CHILD DEATH; CHILD HOSPITALIZATION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FEVER; HUMAN; INFANT; INFLUENZA; INTENSIVE CARE UNIT; LENGTH OF STAY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIXED INFECTION; PARAINFLUENZA VIRUS INFECTION; PNEUMOCOCCAL INFECTION; PNEUMOCOCCAL MENINGITIS; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RETROSPECTIVE STUDY; RHINOVIRUS INFECTION; STREPTOCOCCUS PNEUMONIA; TREATMENT DURATION; VIRUS INFECTION; ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ANALYSIS OF VARIANCE; CHI SQUARE DISTRIBUTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; NONPARAMETRIC TEST; PNEUMOCOCCAL INFECTIONS; PRESCHOOL CHILD; RESPIRATORY TRACT DISEASES; RNA VIRUS; RNA VIRUS INFECTIONS; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; VIROLOGY;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ADOLESCENT; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; PNEUMOCOCCAL INFECTIONS; RESPIRATORY TRACT DISEASES; RETROSPECTIVE STUDIES; RNA VIRUS INFECTIONS; RNA VIRUSES; STATISTICS, NONPARAMETRIC; STREPTOCOCCUS PNEUMONIAE; TEXAS;

EID: 77953163938     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181cdafc2     Document Type: Article

References (31)

1. Cooper DL, Smith GE, Edmunds WJ, et al. The contribution of respiratory pathogens to the seasonality of NHS direct calls. J Infect. 2007;55:240-248.
2. Griffin MR, Walker FJ, Iwane MK, et al. Epidemiology of respiratory infections in young children: insights from the new vaccine surveillance network. Pediatr Infect Dis J. 2004;23:S188-S192.
3. McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev. 2006;19:571-582.
4. Ampofo K, Bender J, Sheng X, et al. Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection. Pediatrics. 2008;122:229-237.
5. Dowell SF, Whitney CG, Wright C, et al. Seasonal patterns of invasive pneumococcal disease. Emerg Infect Dis. 2003;9:573-579.
6. Talbot TR, Poehling KA, Hartert TV, et al. Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation. Am J Med. 2005;118:285-291.
7. Kim PE, Musher DM, Glezen WP, et al. Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. Clin Infect Dis. 1996;22:100-106.
8. Peltola V, Waris M, Hyypia T, et al. Respiratory viruses in children with invasive pneumococcal disease. Clin Infect Dis. 2006;43:266-268.
9. Stensballe LG, Hjuler T, Andersen A, et al. Hospitalization for respiratory syncytial virus infection and invasive pneumococcal disease in Danish children aged <2 years: a population-based cohort study. Clin Infect Dis. 2008;46:1165-1171.
10. Braun LE, Sutter DE, Eichelberger MC, et al. Co-infection of the cotton rat (Sigmodon hispidus) with Staphylococcus aureus and influenza A virus results in synergistic disease. Microb Pathog. 2007;43:208-216.
11. Finelli L, Fiore A, Dhara R, et al. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics. 2008;122:805-811.
12. Kallen AJ, Brunkard J, Moore Z, et al. Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season. Ann Emerg Med. 2009;53:358-365.
13. O'Brien KL, Walters MI, Sellman J, et al. Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin Infect Dis. 2000;30:784-789.
14. Blay A, Bessler H, Lahad A, et al. Does pneumococcal vaccine reduce influenza morbidity in humans? Vaccine. 2007;25:1071-1075.
15. Spaude KA, Abrutyn E, Kirchner C, et al. Influenza vaccination and risk of mortality among adults hospitalized with community-acquired pneumonia. Arch Intern Med. 2007;167:53-59.
16. Messina AF, Katz-Gaynor K, Barton T, et al. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005. Pediatr Infect Dis J. 2007;26:461-467.
17. McCullers JA, Rehg JE. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J Infect Dis. 2002;186:341-350.
18. Hakansson A, Kidd A, Wadell G, et al. Adenovirus infection enhances in vitro adherence of Streptococcus pneumoniae. Infect Immun. 1994;62: 2707-2714.
19. de Roux A, Ewig S, Garcia E, et al. Mixed community-acquired pneumonia in hospitalised patients. Eur Respir J. 2006;27:795-800.
20. Brundage JF, Shanks GD. Deaths from bacterial pneumonia during 1918-19 influenza pandemic. Emerg Infect Dis. 2008;14:1193-1199.
21. Michelow IC, Olsen K, Lozano J, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics. 2004;113:701-707.
22. McCullers JA, Bartmess KC. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J Infect Dis. 2003;187:1000-1009.
23. van der Sluijs KF, Nijhuis M, Levels JH, et al. Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia. J Infect Dis. 2006;193:214-222.
24. van der Sluijs KF, van Elden LJ, Nijhuis M, et al. Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumonia. Am J Physiol Lung Cell Mol Physiol. 2006;290:L194-L199.
25. van der Sluijs KF, van Elden LJ, Nijhuis M, et al. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J Immunol. 2004;172:7603-7609.
26. Bacterial meningitis after influenza. Lancet. 1982;1:804.
27. Krasinski K, Nelson JD, Butler S, et al. Possible association of mycoplasma and viral respiratory infections with bacterial meningitis. Am J Epidemiol. 1987;125:499-508.
28. Kaplan SL, Taber LH, Frank AL, et al. Nasopharyngeal viral isolates in children with Haemophilus influenzae type B meningitis. J Pediatr. 1981; 99:591-593.
29. Lewis PF, Schmidt MA, Lu X, et al. A community-based outbreak of severe respiratory illness caused by human adenovirus serotype 14. J Infect Dis. 2009;199:1427-1434.
30. Tate JE, Bunning ML, Lott L, et al. Outbreak of severe respiratory disease associated with emergent human adenovirus serotype 14 at a US air force training facility in 2007. J Infect Dis. 2009;199:1419-1426.
31. Moro MR, Bonville CA, Suryadevara M, et al. Clinical features, adenovirus types, and local production of inflammatory mediators in adenovirus infections. Pediatr Infect Dis J. 2009;28:376-380.